Analgesic Effect of Ropivacaine Anesthesia Combined with Low-dose Oxytocin throughout the Midwifery on Puerperae with Vaginal Delivery and Its Influence on Maternal and Neonatal Outcomes

  • Yumei Nie
Keywords: Ropivacaine Anesthesia, Low-Dose Oxytocin throughout the Midwifery, Analgesia Effect on Puerpera, Maternal and Neonatal Outcomes

Abstract

To explore the analgesic effect of ropivacaine anesthesia combined with low-dose oxytocin throughout the
midwifery and its influence on maternal and neonatal outcomes. 180 puerperae with vaginal delivery admitted
to our hospital from February 2015 to April 2018 were selected for comparative treatment. They were divided
into treatment group (90 cases) and control group (90 cases) using the random number method. The control
group was given psychological care, while the treatment group was given ropivacaine anesthesia combined with
low-dose oxytocin throughout the midwifery. The pain index (VAS), maternal and neonatal outcomes (rates of
natural childbirth, forceps delivery and cesarean section), the Apgar score of newborns, stage of labor and
amount of postpartum bleeding of two groups were compared and analyzed. After treatment, the VAS score of
the treatment group was obviously lower than before treatment, but the difference was not statistically
significant (P>0.01). After treatment, the rates of natural childbirth, forceps delivery and cesarean section of the
treatment group were significantly lower than those of the control group (P<0.05). After treatment, the Apgar
score of the treatment group was obviously better than that of the control group, and the difference was
statistically significant (P<0.05). After treatment, the first, second and third stages of labor of the treatment
group were significantly shorter than those of the control group (P<0.05), and the amount of postpartum
bleeding was also significantly lower than that of the control group (P<0.05). In the treatment group, there was
no significant difference in levels of SBP, DBP, HR and SpO2 before and after treatment (P>0.05). In the control
group, there was no significant difference in the above levels before analgesia, 10min and 30min after analgesia,
at full cervical dilatation and fetus delivery (P>0.05). Ropivacaine anesthesia combined with low-dose oxytocin
throughout the midwifery can relieve pain caused by childbirth, increase the puerperae’s confidence in
childbirth, relieve their tension, improve the success rate of childbirth and reduce the occurrence of neonatal
asphyxia. It has little effect on the safety of mothers and infants and is worthy of clinical promotion and
application.

Published
2020-02-01